Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy

Sexually Transmitted Infections

Volumn 75, Issue 3, 1999, Pages 168-171

  Arvaja, M ^a   Lehtinen, M ^b   Koskela, P ^b   Lappalainen, M ^c   Paavonen, J ^c   Vesikari, Timo ^a,d  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Glycoprotein gG; Herpes simplex virus; Neonatal herpes; Pregnancy

Indexed keywords

VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; MATERNAL DISEASE; PRIORITY JOURNAL; SEROPREVALENCE;

EID: 0033007790     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.75.3.168     Document Type: Article

References (35)

1. Randolph A, Washington E, Prober C. Cesarean delivery for women presenting with genital herpes lesions. JAMA 1993;270:77-82.
2. Prober C, Sullender W, Yasukawa L, et al. Low risk of herpes simplex virus infection in neonates exposed to the virus at the time of a vaginal delivery to mothers with recurrent herpes simplex virus infection. N Engl J Med 1987;316:240-4.
3. Brown Z, Benedeffi J, Ashley R, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247-52.
4. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
5. Brown Z, Vontver L, Benedeffi J, et al. Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 1987;317:1246-51.
6. Whitley R, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 1991;324:450-4.
7. Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1992;326:1533-9.
8. Arvin AM, Hensleigh PA, Prober CG, et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986;315;796-800.
9. Ashley R, Cent A, Maggs V, et al. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2. Ann Intern Med 1991;115:520-6.
10. Suchankova A, Hirsch I, Kremar M, et al. Determination of herpes simplex virus type-specific antibodies by solid-phase RIA on helix pomatia lectin-purified antigens. J Infect Dis 1984;149:964-72.
11. Lee F, Coleman R, Pereira L, et al. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol 1985;22:641-4.
12. Sullender W, Yasukawa L, Schwartz M, et al. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J Infect Dis 1988;157:164-71.
13. Cowan F, Johnson A, Ashley R, et al. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in population. BMJ 1994;309:1325-9.
14. Sanchez-Martinez D, Schmid DS, Whittington W, et al. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J Infect Dis 1991;164:1196-9.
15. Boucher F, Yasukawa L, Kerns K, et al. Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing glycoprotein gG2. Clin Diagn Virol 1993;1:29-38
16. Lappalainen M, Koskela P, Koskiniemi M, et al. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis 1993;167:691-7.
17. Sanchez-Martinez D, Pellet PE. Expression of HSV-1 and HSV-2 glycoprotein G in insect cells by using a novel baculovirus expression vector. Virology 1991;182:229-38.
18. Lehtinen M, Koivisto V, Lehtinen T, et al. Immunoblotting and enzyme linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2. Intervirology 1985;24:18-25.
19. Lehtinen M, Leminen A, Kuoppala T, et al. Pre- and post-treatment scrum antibody responses to HPV 16 E2 and HSV-2 ICP8 proteins in women with cervical carcinoma. J Med Virol 1992;37:180-6.
20. Bouwes Bavinck J, Gissmann L, Claas F, et al. Relation between skin cancer, humoral responses to human papillomaviruses and HLA class II molecules in renal transplant recipients. J Immunol 1993;151:1579-86.
21. Miettinen A, Paavonen J, Jansson E, et al. Enzyme immunoassay for scrum antibody to mycoplasma hominis in women with acute pelvic inflammatory disease. Sex Transin Dis 1983;10:289-93.
22. Lehtinen M, Parkonnen P, Luoto H, et al. Antipeptide IgA antibodies to a human papillomavirus type 16 H2 derived synthetic peptide predict the natural history of cervical HPV infection. In: Monsonego J ed. Proceedings of the European Multidisciplinary Congress on Human Papillomavirus. New York: Raven Press. Serono Symposia Publ 1990;78:509-19.
23. Nahmias A, Lee F, Beckman-Nahmias S. Seroepidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990;(suppl) 69:19-36.
24. Whitley RJ. Herpes simplex virus infections of women and their offspring:implications for a developed society. Proc Natl Acad Sci USA 1994;91:2441-7.
25. Forsgren M, Skoog E, Jeansson S, et al. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983, and 1989: implications for STD epidemiology. Int J STD AIDS 1994;5:113-6.
26. Persson K, Mansson A, Jonsson E, et al. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 1995;27:195-9.
27. Johnson R, Nahmias A, Magder L, et al. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989;321:7-12.
28. Christenson B, Böttiger M, Svensson A, et al. A 15-year surveillance study of antibodies to herpes simplex virus types 1 and 2 in a cohort of young girls. J Infect 1992;25:147-54.
29. Mertz G, Benedeffi J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202.
30. McGeoch D, Moss H, McNab D, et al. DNA sequence and genetic content of the hindIII I region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. J Gen Virol 1987;68:1938-43.
31. Ashley RL, Corey L, Dalessio J, et al. Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections. J Infect Dis 1994;170:20-6.
32. Stanley C, Lew A, Steward M. The measurement of antibody affinity: a comparison of five techniques utilizing a panel of monoclonal anti-DNP antibodies and the effect of high affinity antibody on the measurement of low affinity antibody. J Immunol Meth 1983;64:119-32.
33. Jones C, MacDonald R, Hosking C, et al. Estimating the relative avidity of mucosal IgA for antigen. J Immunol Meth 1987;105:111-7.
34. Ashley RL, Wu L, Pickering JW, et al. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J Clin Microbiol 1998;36:294-5.
35. Groen J, van Dijk G, Niesters H, et al. Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot for the detection of herpes simplex virus type-2 specific antibodies in scrum. J Clin Microbiol 1998;36:845-847.